Sign In
Buy CO
$2.99
+0 (+0%)
At Close: Sep 08, 2023
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021
04:16pm, Monday, 28'th Jun 2021
Added 19,367 New Subscribers in 4Q21 Revenues Up 0.8% YoY to RMB302.3 million ($46.1 million) Net Income Attributable Up 31.7% YoY to RMB127.7 million ($19.5 million) Operating Cash Flow Up 134.6% YoY
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
07:00am, Tuesday, 22'nd Jun 2021
HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell proces
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
07:00am, Monday, 15'th Mar 2021
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem
Global Cord Blood Corp.: Subscriber Growth Continues With 23% EPS CAGR And 25% FCF Yield
04:52pm, Friday, 26'th Feb 2021
Global Cord Blood had a soft quarter, but subscriber growth continues unabated.
Value Investment Principals' Year-End 2020 Performance And Outlook For 2021
11:23am, Friday, 22'nd Jan 2021
Value Investment Principals' Year-End 2020 Performance And Outlook For 2021
Global Cord Blood Announces NHC Policy Update
07:30am, Tuesday, 05'th Jan 2021
HONG KONG, Jan. 5, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell process
Global Cord Blood Corp.: Solid Subscriber Growth, Net Cash Greater Than Market Cap And High FCF Yield Of 25%
01:38pm, Wednesday, 25'th Nov 2020
CO is a market leader with more net cash than the market cap and our price target is $6.00 [45% upside]. 1HFY2021 results saw total subscriber numbers grow by 10%, despite tough operating conditions.
Global Cord Blood Corporation (CO) CEO Ting Zheng on Q2 2021 Results - Earnings Call Transcript
10:14am, Wednesday, 25'th Nov 2020
Global Cord Blood Corporation (CO) CEO Ting Zheng on Q2 2021 Results - Earnings Call Transcript
Global Cord Blood Corporation: An Undervalued Business But Ownership And Merger Complicate Matters
05:25am, Monday, 31'st Aug 2020
As a business, GCBC's fundamentals impress. Net margins are ~40%, and P/E ratio is ~6.3x, plus the upfront payment/subscription model is attractive.
Global Cord Blood Corporation: June Quarter YoY EPS Of 22%, Subscriber Growth, And Total 183% Net Cash
09:55am, Wednesday, 26'th Aug 2020
June quarter results yielded a 22.3% gain in EPS on tighter cost-controls, subscriber growth, and fee restructuring. Net cash is 183% of the stock price.
Global Cord Blood Corporation (CO) CEO Tina Zheng on Q1 2021 Results - Earnings Call Transcript
11:20am, Tuesday, 25'th Aug 2020
Global Cord Blood Corporation (NYSE:CO) Q1 2021 Earnings Conference Call August 25, 2020 08:00 a.m. ET Company Representatives Tina Zheng - Chief Executive Officer, Director Albert Chen - Chief Financ
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
11:00am, Tuesday, 18'th Aug 2020
Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, toda
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
08:16pm, Wednesday, 29'th Jul 2020
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage ser
Do Hedge Funds Like Global Cord Blood Corp (CO)?
03:49pm, Tuesday, 30'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Edited Transcript of CO earnings conference call or presentation 30-Jun-20 12:00pm GMT
01:25pm, Tuesday, 30'th Jun 2020
Q4 2020 Global Cord Blood Corp Earnings Call
